Akbulut, Hakan <br/><br/>
Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2004 
 - 7738-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-0490  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Camptothecin--analogs & derivatives<br/>Carboxylesterase--metabolism<br/>Cell Line, Tumor<br/>Combined Modality Therapy<br/>Cytosine Deaminase--genetics<br/>Disease Models, Animal<br/>Drug Delivery Systems<br/>Female<br/>Fluorouracil--therapeutic use<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Humans<br/>Inhibitory Concentration 50<br/>Irinotecan<br/>Mice<br/>Mice, Nude<br/>Microscopy, Fluorescence<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Promoter Regions, Genetic<br/>RNA, Messenger--metabolism<br/>Ribosomes--metabolism<br/>Thymidylate Synthase--metabolism<br/>Time Factors<br/>Transcription, Genetic